| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$232,504 |
|
|
|
Indirect Value
|
$203,423 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$435,926 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-10-04 |
4 |
AS |
$40.09 |
$157,976 |
I/I |
(3,900) |
54,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-10-05 |
4 |
AS |
$39.58 |
$155,777 |
I/I |
(3,900) |
50,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-10-22 |
4 |
AS |
$33.66 |
$131,751 |
I/I |
(3,900) |
46,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-10-23 |
4 |
AS |
$33.17 |
$133,045 |
I/I |
(3,900) |
43,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-11-14 |
4 |
AS |
$33.89 |
$132,543 |
I/I |
(3,900) |
39,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-11-15 |
4 |
AS |
$34.67 |
$137,509 |
I/I |
(3,900) |
35,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-11-28 |
4 |
AS |
$38.65 |
$151,803 |
I/I |
(3,900) |
31,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-11-29 |
4 |
AS |
$41.13 |
$163,232 |
I/I |
(3,900) |
27,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-12 |
4 |
AS |
$42.56 |
$165,984 |
I/I |
(3,900) |
23,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-13 |
4 |
AS |
$42.75 |
$166,725 |
I/I |
(3,900) |
19,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-27 |
4 |
AS |
$32.82 |
$128,893 |
I/I |
(3,900) |
15,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-28 |
4 |
AS |
$34.60 |
$135,340 |
I/I |
(3,900) |
11,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-01-09 |
4 |
AS |
$34.51 |
$135,889 |
I/I |
(3,900) |
7,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-01-10 |
4 |
AS |
$33.93 |
$133,581 |
I/I |
(3,900) |
4,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-01-23 |
4 |
AS |
$34.84 |
$136,650 |
I/I |
(3,900) |
300,352 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-01-24 |
4 |
AS |
$34.98 |
$136,783 |
I/I |
(3,900) |
296,452 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,683) |
375,611 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-09 |
4 |
D |
$38.49 |
$782,271 |
D/D |
(20,324) |
334,618 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-11 |
4 |
AS |
$38.52 |
$150,228 |
I/I |
(3,900) |
346,038 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-12 |
4 |
AS |
$39.01 |
$152,139 |
I/I |
(3,900) |
342,138 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-15 |
4 |
D |
$40.45 |
$47,569 |
D/D |
(1,176) |
332,243 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-27 |
4 |
AS |
$35.22 |
$140,984 |
I/I |
(3,900) |
339,437 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-28 |
4 |
AS |
$36.13 |
$140,907 |
I/I |
(3,900) |
335,537 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-14 |
4 |
AS |
$39.10 |
$156,906 |
I/I |
(3,900) |
331,637 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-15 |
4 |
AS |
$38.73 |
$151,047 |
I/I |
(3,900) |
327,737 |
0 |
- |
|
209 Records found
|
|
Page 8 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
